These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18499785)

  • 1. Quantitative cerebrovascular reserve measured by acetazolamide-challenged dynamic CT perfusion in ischemic adult Moyamoya disease: initial experience with angiographic correlation.
    Kang KH; Kim HS; Kim SY
    AJNR Am J Neuroradiol; 2008 Sep; 29(8):1487-93. PubMed ID: 18499785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral hemodynamics and metabolism in adult moyamoya disease: comparison of angiographic collateral circulation.
    Piao R; Oku N; Kitagawa K; Imaizumi M; Matsushita K; Yoshikawa T; Takasawa M; Osaki Y; Kimura Y; Kajimoto K; Hori M; Hatazawa J
    Ann Nucl Med; 2004 Apr; 18(2):115-21. PubMed ID: 15195758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic stress distribution reflects ischemic clinical symptoms of patients with moyamoya disease.
    Takahashi S; Tanizaki Y; Kimura H; Akaji K; Nakazawa M; Yoshida K; Mihara B
    Clin Neurol Neurosurg; 2015 Nov; 138():104-10. PubMed ID: 26318361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT perfusion with angiography as a substitute for both conventional digital subtraction angiography and acetazolamide-challenged SPECT in the follow-up of postbypass patients.
    Park JC; Kim JE; Kang HS; Sohn CH; Lee DS; Oh CW; Han MH
    Cerebrovasc Dis; 2010; 30(6):547-55. PubMed ID: 20948198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which CT perfusion parameter best reflects cerebrovascular reserve?: correlation of acetazolamide-challenged CT perfusion with single-photon emission CT in Moyamoya patients.
    Rim NJ; Kim HS; Shin YS; Kim SY
    AJNR Am J Neuroradiol; 2008 Oct; 29(9):1658-63. PubMed ID: 18617583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constant-infusion H(2)15O PET and acetazolamide challenge in the assessment of cerebral perfusion status.
    Weber B; Westera G; Treyer V; Burger C; Khan N; Buck A
    J Nucl Med; 2004 Aug; 45(8):1344-50. PubMed ID: 15299060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique Angiographic Appearances of Moyamoya Disease Detected with 3-Dimensional Rotational Digital Subtraction Angiography Imaging Showing the Hemodynamic Status.
    Karakama J; Nariai T; Hara S; Hayashi S; Sumita K; Inaji M; Tanaka Y; Wagatsuma K; Ishii K; Nemoto S; Maehara T
    J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2147-2157. PubMed ID: 29653803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic CT perfusion imaging with acetazolamide challenge for evaluation of patients with unilateral cerebrovascular steno-occlusive disease.
    Chen A; Shyr MH; Chen TY; Lai HY; Lin CC; Yen PS
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):1876-81. PubMed ID: 17032859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CT perfusion imaging in evaluating the effects of multiple burr hole surgery on adult ischemic Moyamoya disease.
    Dai DW; Zhao WY; Zhang YW; Yang ZG; Li Q; Xu B; Ma XL; Tian B; Liu JM
    Neuroradiology; 2013 Dec; 55(12):1431-8. PubMed ID: 24153446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral blood flow, transit time, and apparent diffusion coefficient in moyamoya disease before and after acetazolamide.
    Federau C; Christensen S; Zun Z; Park SW; Ni W; Moseley M; Zaharchuk G
    Neuroradiology; 2017 Jan; 59(1):5-12. PubMed ID: 27913820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfusion-CT assessment of the cerebrovascular reserve: a revisit to the acetazolamide challenges.
    Smith LM; Elkins JS; Dillon WP; Schaeffer S; Wintermark M
    J Neuroradiol; 2008 Jul; 35(3):157-64. PubMed ID: 18242708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-course analysis of brain perfusion single photon emission computed tomography using a three-dimensional stereotactic region-of-interest template in patients with moyamoya disease.
    Marushima A; Tsurushima H; Suzuki K; Nakai Y; Nemoto H; Matsumura A
    World Neurosurg; 2011; 76(3-4):304-10. PubMed ID: 21986429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Hemodynamic Compromise Using Computed Tomography Perfusion in Combination with
    Hashimoto A; Mikami T; Komatsu K; Noshiro S; Hirano T; Wanibuchi M; Mikuni N
    J Stroke Cerebrovasc Dis; 2017 Mar; 26(3):627-635. PubMed ID: 27939758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged Mean Transit Time Detected by Dynamic Susceptibility Contrast Magnetic Resonance Imaging Predicts Cerebrovascular Reserve Impairment in Patients with Moyamoya Disease.
    Kawano T; Ohmori Y; Kaku Y; Muta D; Uekawa K; Nakagawa T; Amadatsu T; Kasamo D; Shiraishi S; Kitajima M; Kuratsu J
    Cerebrovasc Dis; 2016; 42(1-2):131-8. PubMed ID: 27088711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-brain CT perfusion and CT angiography assessment of Moyamoya disease before and after surgical revascularization: preliminary study with 256-slice CT.
    Zhang J; Wang J; Geng D; Li Y; Song D; Gu Y
    PLoS One; 2013; 8(2):e57595. PubMed ID: 23451248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative H2[(15)O]-PET in Pediatric Moyamoya Disease: Evaluating Perfusion before and after Cerebral Revascularization.
    Kuhn FP; Warnock G; Schweingruber T; Sommerauer M; Buck A; Khan N
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):965-71. PubMed ID: 25813061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial spin-labeling MR imaging in moyamoya disease compared with SPECT imaging.
    Noguchi T; Kawashima M; Irie H; Ootsuka T; Nishihara M; Matsushima T; Kudo S
    Eur J Radiol; 2011 Dec; 80(3):e557-62. PubMed ID: 21315533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prior Infarcts, Reactivity, and Angiography in Moyamoya Disease (PIRAMD): a scoring system for moyamoya severity based on multimodal hemodynamic imaging.
    Ladner TR; Donahue MJ; Arteaga DF; Faraco CC; Roach BA; Davis LT; Jordan LC; Froehler MT; Strother MK
    J Neurosurg; 2017 Feb; 126(2):495-503. PubMed ID: 26967789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of cerebral hemodynamics assessed by CT perfusion in moyamoya disease.
    Sasagawa A; Mikami T; Hirano T; Akiyama Y; Mikuni N
    J Clin Neurosci; 2018 Jan; 47():183-189. PubMed ID: 29056445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood Moyamoya disease.
    Touho H; Karasawa J; Ohnishi H
    Stroke; 1996 Feb; 27(2):282-9. PubMed ID: 8571424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.